Greenleaf Trust’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-32,816
Closed -$461K 754
2022
Q3
$461K Buy
+32,816
New +$620K 0.01% 423
2018
Q4
Sell
-8,380
Closed -$431K 516
2018
Q3
$431K Sell
8,380
-1,532
-15% -$76.7K 0.01% 310
2018
Q2
$499K Buy
9,912
+1,316
+15% +$66.7K 0.01% 270
2018
Q1
$439K Buy
8,596
+372
+5% +$19.8K 0.01% 261
2017
Q4
$432K Hold
8,224
0.01% 269
2017
Q3
$402K Buy
8,224
+3,232
+65% +$154K 0.01% 265
2017
Q2
$241K Buy
4,992
+126
+3% +$5.8K 0.01% 314
2017
Q1
$205K Buy
+4,866
New +$201K ﹤0.01% 287

Other funds holding FMS

Greenleaf Trust's FMS Position: Q4 2022 in Review

Greenleaf Trust sold out of Fresenius Medical Care (FMS) in Q4 2022, closing a stake of 32,816 shares — an estimated $461K sold.

Greenleaf Trust first reported a position in FMS in Q1 2017 and held it in 8 quarters. The position peaked at $499K in Q2 2018. 155 funds tracked by Wall St. Rank hold FMS as of Q4 2022.

  • Greenleaf Trust reported no remaining Fresenius Medical Care position as of Q4 2022 after selling out during the quarter.
  • Greenleaf Trust sold 32,816 Fresenius Medical Care shares in Q4 2022, an estimated $461K.
  • Greenleaf Trust first reported a position in Fresenius Medical Care in Q1 2017 and held it in 8 quarters.
  • Greenleaf Trust's Fresenius Medical Care position peaked at $499K in Q2 2018.
  • 155 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2022.

Based on Greenleaf Trust's 13F filing for Q4 2022, filed 25 Jan 2023.